Bradesco: A Cheap, Convincing Turnaround — Buy the Recovery

Hook & thesis

Banco Bradesco (NYSE: BBD) looks like a classic value-with-momentum opportunity. The bank is cheap on headline metrics - a market cap near $36.9 billion, a price-to-earnings ratio of ~8.2 and price-to-book around 1.08 - yet the share price has already begun a measured recovery: moving averages are rising, MACD shows bullish momentum and short interest has declined meaningfully over the summer. For investors who believe Brazil's macro and the domestic banking cycle have turned less hostile, Bradesco offers asymmetric upside versus the current downside.

Why the market should care

Bradesco is Brazil's large, diversified private bank with both traditional banking and a substantial insurance arm. The business mix matters: banking provides core deposit and lending flows while insurance delivers higher-margin, recurring revenue and cross-sell leverage. That combination gives Bradesco optionality: improving credit trends help lending margins and reserves, while steady insurance penetration supports fee income and ROE.

What the numbers say

At the current quote of $3.46, the shares trade below the 10- and 20-day SMAs ($3.52 and $3.44 respectively are recent reads) but above the 50-day SMA ($3.418), which suggests a rolling base with room to run. Momentum indicators are constructive: RSI sits around 51.8 (neutral), MACD is slightly positive with a bullish histogram, and the 9-day EMA ($3.493) is near the price, indicating short-term consolidation ahead of a likely push higher.

Operationally, Bradesco's publicly available profile highlights a diversified revenue base: banking and insurance. The insurance franchise historically contributes stable fee income and can act as an earnings stabilizer when credit cycles turn volatile. Management continuity under CEO Marcelo de Araújo Noronha and a large float (roughly 5.58 billion shares) improve liquidity for institutional rotations that often drive multi-week moves in the stock.

Why now: technical and sentiment set-up

• Momentum is constructive: the MACD line and signal are positive and the histogram has turned bullish, which often precedes multi-week rallies in bank names.
• Short interest has contracted from a mid-May peak (e.g., ~62.3 million on 05/15/2026) to ~20.85 million on 08/31/2026 - this reduction lowers the risk of a crowded short squeeze but also signals fewer sustained downward pressures from forced covering.
• Volume is meaningful: two-week average volume sits in the mid-20 million range and recent sessions have traded above that, indicating institutional participation on both sides.

Valuation framing

At a market cap near $36.9 billion and a PE ~8.2, Bradesco trades in territory consistent with underappreciated earnings power. A PB around 1.08 implies the market assigns a modest premium to book, but not an escape valuation. Historically, large Brazilian banks can trade at higher multiples when credit conditions normalize and earnings visibility improves. If margins re-expand and reserve releases slow, getting back toward even a PE of 10-12 would imply meaningful upside from here.

Catalysts (what could drive the stock higher)

• Continued stabilization in credit costs - lower provisioning would translate straight to EPS upside.
• Improving net interest margins as loan repricing and deposit mix shift favorably.
• Insurance segment growth and margin recovery lifting group ROE and demonstrating earnings diversity.
• Macro tailwinds for Brazilian financials - any signs of firmer local rates or better GDP data that increase credit demand and deposit spreads.
• Shareholder-friendly actions: dividend increases or buybacks (the company has paid dividends previously, with a per-share distribution of $0.036497 and upcoming payable date 09/25/2026) that would tighten free float and signal confidence.

Trade plan (actionable)

Thesis: Buy the ongoing recovery while the stock is cheap and exhibits improving technicals.

Entry price: Buy at $3.46.

Stop loss: $3.00 - this level sits below the recent low and close to the 52-week low, offering a clear invalidation point for the recovery thesis.

Target price: $4.30 - the 52-week high and the first realistic upside milestone given the stock’s recent trading range and valuation.

Horizon: Long term (180 trading days). I expect the combination of easing credit headwinds, insurance resilience and positive macro signals to play out over several months; the 180 trading day horizon (roughly 6-9 months) allows time for earnings beats, reserve normalization, or a re-rating to materialize.

Position sizing suggestion: Treat this as a medium-risk position: size such that a stop at $3.00 represents acceptable portfolio downside. Because liquidity is good, you can scale in around $3.40-$3.50 to improve execution.

Risks & counterarguments

• Macro tail risk: Brazil-specific shocks (currency weakness, political instability, or higher-than-expected inflation) can compress multiples further even if the bank’s fundamentals are improving.
• Credit deterioration persists: if delinquency or loss given default worsens, reserves may need to rise and EPS could be hit despite current momentum.
• Insurance exposure: an unexpected underwriting shock or large catastrophe loss could pressure consolidated profitability and offset any banking gains.
• Valuation trap: low multiples may reflect structural issues (competition, profitability pressure) rather than temporary cyclical weakness; the market may re-rate more slowly than expected.
• Technical risk: while momentum looks constructive, the price is still within a tight range. A break below $3.00 would suggest the recovery failed and could lead to another leg lower toward the recent low of $2.98.

Counterargument: Goldman Sachs maintained a Sell rating and reduced its price target in early 2024, a reminder that some institutional desks remain skeptical. If macro and credit risks reassert, the market can re-price Bradesco down to reflect slower earnings recovery. That is the primary alternative scenario to the bullish case.

What would change my mind

I will reduce conviction if any of the following occur: (1) provisioning trends re-accelerate and quarterly reserve builds surprise to the upside, (2) the insurance business reports persistent margin erosion or large claims that meaningfully reduce group ROE, or (3) macro indicators for Brazil deteriorate materially (currency slide >10% in a short span or clear fiscal slippage). Conversely, accelerating NIMs, reserve releases or a visible shareholder return program would increase my conviction and warrant a higher target.

Conclusion

Bradesco currently offers a compelling mix of value and improving technicals. At $3.46 the stock trades cheaply on absolute multiples (PE ~8.2) and book value near 1.08, while short interest has come down from earlier peaks and momentum measures are constructive. The trade is not free of risk - Brazil remains a cyclical market and credit trends deserve close monitoring - but for patient, position-oriented investors willing to hold for up to 180 trading days, buying a recovery at these levels with a stop under $3.00 and a target at $4.30 makes practical sense.

Key data points to watch over the next 3-6 months:

• Quarterly release headlines on provisioning and insurance margins.
• Local macro and FX movements that influence net interest margins and credit demand.
• Volume and short interest trends - a renewed drop in short interest alongside rising volume would signal institutional conviction.